Zhaoru Dong

9PUBLICATIONS
22CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsCancer cell biologyHaematological tumoursPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jun 29, 2026
Multimodal Modeling Distinguishes Treatment Response from Overall Survival in Hepatocellular Carcinoma Receiving Combined Interventional and Targeted Immunotherapy.

|Aug 25, 2025
Targeting FAM111B attenuates mitophagy and increases the sensitivity to lenvatinib treatment by increasing MFN2 stability in hepatocellular carcinoma.

Yu-Chuan Yan, Li-Juan Shao, Guang-Xiao Meng

|Jul 31, 2025
Hypoxia-Induced Creatine Uptake Reprograms Metabolism to Antagonize PARP1-Mediated Cell Death and Facilitate Tumor Progression in Hepatocellular Carcinoma.

Rui-Zhe Li, Guo-Qiang Pan, Chen Xiong

|Mar 07, 2025
Thyroid hormones inhibit tumor progression and enhance the antitumor activity of lenvatinib in hepatocellular carcinoma via reprogramming glucose metabolism.

Chun-Cheng Yang, Yu-Chuan Yan, Guo-Qiang Pan

|Jul 30, 2024
DAP3 promotes mitochondrial activity and tumour progression in hepatocellular carcinoma by regulating MT-ND5 expression.

Siyu Tan, Xiao Zhang, Xiaowei Guo

|Apr 30, 2024
Role of hepatitis B core-related antigen in predicting the occurrence and recurrence of hepatocellular carcinoma in patients with chronic hepatitis B: A systemic review and meta-analysis.

Qi-Hang Cao, Hui Liu, Lun-Jie Yan

Pageof 2

Frequent Collaborators

8 joint publications

Tao Li

3 joint publications

Lun-Jie Yan

2 joint publications

Zi-Niu Ding

2 joint publications

Dongxu Wang